Procalcitonin for the diagnosis of invasive candidiasis: What is the evidence?

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)


Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.
Original languageEnglish
Pages (from-to)58-
Number of pages2
JournalJournal of Intensive Care
Publication statusPublished - 2017

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Procalcitonin for the diagnosis of invasive candidiasis: What is the evidence?'. Together they form a unique fingerprint.

Cite this